Clinical Trials & Research Risks
Delays, adverse events or protocol deviations can lead to significant financial and regulatory consequences.

Life science businesses face unique risks, from regulatory compliance to product liability and clinical exposures. Our underwriting approach is designed to address these challenges with precision and flexibility, delivering tailored solutions aligned with real-world operations. We work closely with brokers and clients to ensure clarity, responsiveness and reliable protection.
Delays, adverse events or protocol deviations can lead to significant financial and regulatory consequences.
Mistakes in research, advisory or clinical services may result in liability claims and reputational damage.
Defects or unforeseen side effects in medical products can trigger serious legal and financial exposure.
Strict frameworks and evolving regulations create exposure if processes are not properly aligned.
Sensitive health data must be securely managed to avoid breaches and compliance violations.
Unauthorized use of formulas, patents or research data can lead to disputes and financial loss.

Protects against risks arising from clinical studies, including participant injury, protocol deviations and regulatory exposure.

Covers claims related to medical products, pharmaceuticals or devices, including adverse effects and end-user impact.

Protects against errors in research, advisory or scientific services, ensuring coverage for professional liability claims.

Protects against data breaches, cyber threats and sensitive information exposure, ensuring resilience in digital operations.
We work closely with life science companies, research organizations and healthcare innovators across diverse sectors, building a strong network of expertise and insight. Through collaboration and a deep understanding of regulatory and clinical risks, we deliver tailored solutions that support growth, resilience and long-term success in a highly controlled environment.
R&D Underwriting has been a reliable partner in helping us navigate complex regulatory and product liability risks. Their understanding of the life science sector and responsiveness made a real difference when structuring our coverage.
Dr. Emily Carter – Head of Clinical Affairs, Biotech Company
Our team is here to support brokers and life science companies with tailored underwriting solutions. Whether you need guidance on regulatory, clinical or product-related risks, we provide clear, responsive and reliable support every step of the way.